3i announces three new hires in its Private Equity team in Amsterdam, reinforcing its strength in northern Europe.
Reinier de Jong has joined as an Associate Director. Before joining 3i, Reinier was a Manager at Bain & Company, and prior to this worked at Morgan Stanley.
Justin Pabst has joined as an Associate. Before joining 3i, Justin was a Commercial Project Manager at Coolblue, and prior to this worked at McKinsey & Company.
Jelle Klein Teeselink has joined as an Analyst. He holds a Masters in Financial Engineering & Management from the University of Twente.
3i’s Private Equity business announced another strong quarter to 31 December 2017, with cash realisations of £389 million in the nine months since 31 March 2017. It announced the c. €307 million divestment of ATESTEO in December 2017, generating a euro money multiple of 4.4x and completed add-on investments in Cirtec Medical (Vascotube) and Ponroy Santé (Aragan). In February, 3i announced its proposed investment in Royal Sanders, a leading European private label and contract manufacturing producer of personal care products.
Pieter de Jong, Managing Partner of the Amsterdam office, commented:
“We would like to offer a warm welcome to our new colleagues in Amsterdam. We look forward to working with them and the team will benefit from their skills and experience in seeking attractive mid-market investment opportunities in the Benelux and Nordics.”